Manhattan Pharmaceuticals plans $25 million private placement of stock

OPN Capital Markets and National Securities are the placement agents

By Devika Patel

Knoxville, Tenn., Jan. 6 - Manhattan Pharmaceuticals, Inc. negotiated a $25 million private placement of stock and warrants on Dec. 30, according to an 8-K filed Friday with the Securities and Exchange Commission. OPN Capital Markets and National Securities Corp. will be the agents for the deal, which must raise at least $15 million.

Michael S. Weiss will invest $300,000, and Lindsay A. Rosenwald will invest $600,000.

New York-based Manhattan Pharmaceuticals is a specialty health care products company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.